This was assessed by detecting the changes in interrupted glucose metabolism via estimation of serum glucose, insulin, the adipocytokine “adiponectin,” homeostasis model assessment of insulin resistance (HOMA-IR) index, and lipid profile. The gene discussed is INS; the disease is Insulin resistance.